NovaBay Pharmaceuticals to Present at Two Investment Conferences in September

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical company focusing on commercializing Avenova® for the domestic eye care market, announces that management will present at two upcoming investment conferences: RHK Capital 4th Annual Disruptive Growth Conference on Thursday, September 5 at 11:00 a.m. Eastern time. The conference is being hosted by Reed Smith LLP in New York City; Ladenburg Thalmann 2019 Healthcare Conference on Tuesday, Septem

Full Story →